Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000232554

Medchemexpress LLC ML339 | 2579689-83-9 | 99.9% | 5 MG
SDP

Catalog No. 5000232554
Encompass_Preferred

ML339 (CAS 2579689-83-9) is a selective antagonist of the chemokine receptor CXCR6 used in receptor signaling and prostate cancer research. It is supplied as a high-purity solid and has been characterized in functional assays showing nanomolar activity against human CXCR6.

  • Selective CXCR6 antagonist (IC50 140 nM).
  • Active in human β-arrestin and cAMP assays (0.3 μM and 1.4 μM).
  • Markedly less active at mouse CXCR6 (IC50 18 μM).
  • High supplied purity (99.88%) and solid powder form.
  • Recommended storage: powder -20°C (long term), 4°C (short term); in solvent -80°C.
  • Molecular weight 502.00; formula C26H32ClN3O5.

Catalog No. 50-002-32554 Supplier Medchemexpress LLC Supplier No. HY1221975MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ML339 (CAS 2579689-83-9) is a selective antagonist of the chemokine receptor CXCR6 used in receptor signaling and prostate cancer research. It is supplied as a high-purity solid and has been characterized in functional assays showing nanomolar activity against human CXCR6.

  • Selective CXCR6 antagonist (IC50 140 nM).
  • Active in human β-arrestin and cAMP assays (0.3 μM and 1.4 μM).
  • Markedly less active at mouse CXCR6 (IC50 18 μM).
  • High supplied purity (99.88%) and solid powder form.
  • Recommended storage: powder -20°C (long term), 4°C (short term); in solvent -80°C.
  • Molecular weight 502.00; formula C26H32ClN3O5.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.